Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is increasingly used in patients with cardiogenic shock despite the lack of evidence from adequately powered randomised clinical trials. Three trials reported so far were underpowered to detect a survival benefit; we therefore conducted an individual patient-based meta-analysis to assess the effect of VA-ECMO on 30-day death rate.
Each week, we choose a study that we believe will be of interest to the interventional cardiology community and discuss it at a virtual Journal Club with several of our faculty members.
Panelists
Presenter
